The core strength of our Biologics division is the
ability to develop biosimilar products from the cloning
stage, covering all aspects of development including
establishing biosimilarity in quality, safety & efficacy.
Grasustek, a Pegfilgrastim biosimilar is approved in EU via centralised procedure.
Two of our biosimilars, Teriparatide and Somatropin have received marketing authorization in India. .
Read more...
